Patients' Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease: lessons learned from the German National Registry

J Eur Acad Dermatol Venereol
20 October 2023
https://pubmed.ncbi.nlm.nih.gov/37863661/

Background: Hailey-Hailey disease (HHD) remains a difficult-to-treat dermatosis and little is known about the patient's perception of the disease activity, the treatment success, and its impact on quality-of-life (QoL).

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus

Case Reports; JAAD Case Rep
19 June 2023
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339115/

Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I'm your host Linda Elsegood. Today we're joined by Ray Solano from PD Labs. He's also a nutritionist. Could you tell us a bit of background about yourself?

The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details

Asher Goldstein, MD - LDN Radio Show 2022 (LDN; low dose naltrexone)

Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone

J Clin Aesthet Dermatol
November 2020
https://www.academia.edu/79471188/Recalcitrant_Hailey_Hailey_Disease_Successfully_Treated_with_Low_dose_Naltrexone?email_work_card=title